Novartis Newswire (Page 3)

Novartis Newswire (Page 3)

Comprehensive Real-Time News Feed for Novartis. (Page 3)

Results 41 - 60 of 2,098 in Novartis

  1. Clear Perspective Advisors LLC Sells 350 Shares of Novartis AGRead the original story w/Photo

    Wednesday Oct 4 | Daily Political

    Clear Perspective Advisors LLC cut its holdings in Novartis AG by 3.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,976 shares of the company's stock after selling 350 shares during the period.

    Comment?

  2. Novartis AG (NVS) Stake Maintained by San Francisco Sentry Investment Group CARead the original story w/Photo

    Wednesday Oct 4 | Daily Political

    San Francisco Sentry Investment Group CA held its position in Novartis AG during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,000 shares of the company's stock at the end of the 2nd quarter.

    Comment?

  3. Novartis AG (NVS) Stake Decreased by Punch & Associates Investment Management Inc.Read the original story w/Photo

    Wednesday Oct 4 | Daily Political

    Punch & Associates Investment Management Inc. decreased its holdings in Novartis AG by 1.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,816 shares of the company's stock after selling 524 shares during the period.

    Comment?

  4. Teva Receives Big Blow On Generics PricingRead the original story w/Photo

    Wednesday Oct 4 | Seeking Alpha

    ... it this way, sales of Copaxone were already falling behind schedule due to competition. This competition came from Novartis ( NVS ) and Momenta Pharmaceuticals ( MNTA ), which together launched a 20 mg generic version of Copaxone known as Glatopa. ...

    Comment?

  5. Novartis AG (NVS) Short Interest Down 33.5% in SeptemberRead the original story w/Photo

    Wednesday Oct 4 | AmericanBankingNews.com

    Novartis AG was the recipient of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 1,327,917 shares, a drop of 33.5% from the August 31st total of 1,996,918 shares.

    Comment?

  6. Logan Capital Management Inc. Increases Position in Novartis AGRead the original story w/Photo

    Tuesday Oct 3 | Daily Political

    Logan Capital Management Inc. increased its position in Novartis AG by 1.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,861 shares of the company's stock after purchasing an additional 200 shares during the quarter.

    Comment?

  7. Samlyn Capital LLC Has $19.12 Million Holdings in Novartis AGRead the original story w/Photo

    Tuesday Oct 3 | IntersportsWire

    Samlyn Capital LLC trimmed its stake in Novartis AG by 31.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 229,100 shares of the company's stock after selling 106,600 shares during the quarter.

    Comment?

  8. A Starting Point For Big Pharma: Do Novartis And Sanofi Clear The Hurdles?Read the original story w/Photo

    Monday Oct 2 | Seeking Alpha

    Investors focused on return metrics should critically review the value creation ability of pharma companies like Novartis and Sanofi and size positions accordingly. Not all big pharmaceutical companies are able to translate their strong market positioning into truly attractive levels of return for investors seeking high levels of value creation.

    Comment?

  9. Novartis AG (NVS) Stake Lowered by Boston Common Asset Management LLCRead the original story w/Photo

    Sunday Oct 1 | IntersportsWire

    Boston Common Asset Management LLC reduced its stake in Novartis AG by 3.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 131,508 shares of the company's stock after selling 4,257 shares during the quarter.

    Comment?

  10. First City Capital Management Inc. Continues to Hold Position in Novartis AGRead the original story w/Photo

    Sunday Oct 1 | IntersportsWire

    First City Capital Management Inc. continued to hold its position in shares of Novartis AG during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 6,506 shares of the company's stock at the end of the second quarter.

    Comment?

  11. Novartis AG (NVS) Holdings Maintained by First Light Asset Management LLCRead the original story w/Photo

    Sunday Oct 1 | Daily Political

    First Light Asset Management LLC maintained its position in shares of Novartis AG during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,572 shares of the company's stock at the end of the second quarter.

    Comment?

  12. Uspto Ok's Argentum's challenge to Novartis Afinitor patentRead the original story w/Photo

    Friday Sep 29 | Seeking Alpha

    The USPTO's Patent Trial and Appeal Board grants a petition from generic drug maker Argentum Pharmaceuticals for inter partes review of Novartis' U.S. Patent No. 9,006,224 covering AFINITOR after determining that Argentum would likely prevail in challenging claims 1-3 of the patent.

    Comment?

  13. USPTO OKs Argentum challenge to Alcon Travatan patentRead the original story w/Photo

    Friday Sep 29 | Seeking Alpha

    The USPTO's Patent Trial and Appeal Board grants a petition from generic drug maker Argentum Pharmaceuticals for inter partes review of the last-expiring patent covering Novartis unit Alcon's eye drop TRAVATAN Z . Argentum is challenging claims 1-28 of U.S. Patent No.

    Comment?

  14. Novartis AG (NVS) Position Trimmed by Stifel Financial CorpRead the original story w/Photo

    Friday Sep 29 | Daily Political

    Stifel Financial Corp trimmed its position in shares of Novartis AG by 15.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 255,622 shares of the company's stock after selling 45,638 shares during the period.

    Comment?

  15. Better Healthcare Dividend Stock: Pfizer Or Novartis?Read the original story w/Photo

    Friday Sep 29 | Seeking Alpha

    ... dividend stocks. Investors can find no shortage of 3%+ yields from the healthcare sector. Pfizer ( PFE ) and Novartis ( NVS ) are similar stocks. They are both health care giants, with market capitalizations of $211 billion and $195 billion, ...

    Comment?

  16. Pfizer, Eli Lilly respond to reports of drug shortages from Puerto Rico damageRead the original story

    Friday Sep 29 | Fox News

    ... the manufacturing sites this past week. We are working to address any urgent support needs they have," Hull added. Novartis ( NVS ) said while it does not have manufacturing facilities in Puerto Rico, it is working closely with its partners, ...

    Comment?

  17. VEA, JPNL: Big ETF InflowsRead the original story

    Friday Sep 29 | MarketNewsVideo

    Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel, the biggest inflow was seen in the Vanguard FTSE Developed Markets ETF , which added 12,003,113 units, or a 0.8% increase week over week. Among the largest underlying components of VEA, in morning trading today Nestle is trading flat, and Novartis is higher by about 0.6%.

    Comment?

  18. Novartis AG (NVS) Earns Daily Media Sentiment Score of 0.14Read the original story w/Photo

    Thursday Sep 28 | IntersportsWire

    Media headlines about Novartis AG have been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by reviewing more than 20 million blog and news sources.

    Comment?

  19. Novartis Ag (NVS) Rating Reiterated by J P Morgan Chase & CoRead the original story w/Photo

    Thursday Sep 28 | IntersportsWire

    ... Several other analysts have also recently commented on NVS. UBS AG restated a "neutral" rating on shares of Novartis AG in a report on Tuesday, May 30th. BidaskClub cut Novartis AG from a "hold" rating to a "sell" rating in a report on Friday, ...

    Comment?

  20. Novartis Is Said to Eye Deal for Radioactive-Drug Maker AAARead the original story

    Thursday Sep 28 | The Washington Post

    Novartis AG is considering a deal for radiopharmaceutical company Advanced Accelerator Applications SA as the giant Swiss drugmaker seeks acquisitions to boost growth, according to people familiar with the matter. Novartis has approached AAA, as the company is known, about a deal and held talks, the people said, asking not to be identified because the deliberations are private.

    Comment?